These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16213773)

  • 1. Cutaneous lymphocytic vasculitis during TNFalpha antagonist therapy for polyarthritis.
    Wendling D; Streit G; Lehuédé G; Toussirot E; Aubin A; Petitjean A
    Joint Bone Spine; 2006 Mar; 73(2):215-6. PubMed ID: 16213773
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous vasculitis induced by TNF inhibitors: a report of three cases.
    Fujikawa K; Kawakami A; Hayashi T; Iwamoto N; Kawashiri SY; Aramaki T; Ichinose K; Tamai M; Arima K; Kamachi M; Yamasaki S; Nakamura H; Ida H; Origuchi T; Eguchi K
    Mod Rheumatol; 2010 Feb; 20(1):86-9. PubMed ID: 19812889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous vasculitis associated with infliximab in the treatment of rheumatoid arthritis.
    Anandacoomarasamy A; Kannangara S; Barnsley L
    Intern Med J; 2005 Oct; 35(10):638-40. PubMed ID: 16207269
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-tumour necrosis factor therapy associated with cutaneous vasculitis.
    Livermore PA; Murray KJ
    Rheumatology (Oxford); 2002 Dec; 41(12):1450-2. PubMed ID: 12468829
    [No Abstract]   [Full Text] [Related]  

  • 5. Cutaneous mucormycosis complicating methotrexate, prednisone, and infliximab therapy.
    Gadadhar H; Hawkins S; Huffstutter JE; Panda M
    J Clin Rheumatol; 2007 Dec; 13(6):361-2. PubMed ID: 18176152
    [No Abstract]   [Full Text] [Related]  

  • 6. Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents.
    Mohan N; Edwards ET; Cupps TR; Slifman N; Lee JH; Siegel JN; Braun MM
    J Rheumatol; 2004 Oct; 31(10):1955-8. PubMed ID: 15468359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leucocytoclastic vasculitis associated with golimumab.
    Pàmies A; Castro S; Poveda MJ; Fontova R
    Rheumatology (Oxford); 2013 Oct; 52(10):1921-3. PubMed ID: 23530254
    [No Abstract]   [Full Text] [Related]  

  • 8. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.
    Lipsky PE; van der Heijde DM; St Clair EW; Furst DE; Breedveld FC; Kalden JR; Smolen JS; Weisman M; Emery P; Feldmann M; Harriman GR; Maini RN;
    N Engl J Med; 2000 Nov; 343(22):1594-602. PubMed ID: 11096166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocytoclastic vasculitis: A rare adverse effect secondary to infliximab.
    Karoui S; Bibani N; Ben Gorbel I; Serghini M; Mlika M; Braham A; Chelly I; Haouet S; Houmène H; Filali A
    Inflamm Bowel Dis; 2011 Feb; 17(2):E4-5. PubMed ID: 20848511
    [No Abstract]   [Full Text] [Related]  

  • 10. Should anti-tumor necrosis factor-alpha be the first therapy for rheumatoid vasculitis?
    Garcia-Porrua C; Gonzalez-Gay MA; Quevedo V
    J Rheumatol; 2006 Feb; 33(2):433; author reply 433-4. PubMed ID: 16465676
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-tumour necrosis factor treatment with infliximab in a case of giant cell arteritis resistant to steroid and immunosuppressive drugs.
    Airò P; Antonioli CM; Vianelli M; Toniati P
    Rheumatology (Oxford); 2002 Mar; 41(3):347-9. PubMed ID: 11934977
    [No Abstract]   [Full Text] [Related]  

  • 12. Rituximab-induced vasculitis: A case report and review of the medical published work.
    Kim MJ; Kim HO; Kim HY; Park YM
    J Dermatol; 2009 May; 36(5):284-7. PubMed ID: 19382999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and adverse reactions of the TNFalpha inhibitor infliximab in rheumatoid arthritis].
    Imagama T; Taguchi T
    Nihon Rinsho; 2013 Jul; 71(7):1209-13. PubMed ID: 23961668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [First scientific meeting of CRI (Rheumatism and Inflammation Club) under the patronage of FNSIM (French National Society of Internal Medicine) and FSR(French Society of Rheumatology) Paris, May 4, 2002].
    Grateau G; Geffray L; Veyssier-Belot C
    Rev Med Interne; 2002 Oct; 23(10):805-7. PubMed ID: 12428480
    [No Abstract]   [Full Text] [Related]  

  • 15. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.
    Smolen JS; Kay J; Doyle MK; Landewé R; Matteson EL; Wollenhaupt J; Gaylis N; Murphy FT; Neal JS; Zhou Y; Visvanathan S; Hsia EC; Rahman MU;
    Lancet; 2009 Jul; 374(9685):210-21. PubMed ID: 19560810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymyositis associated with infliximab treatment for rheumatoid arthritis.
    Urata Y; Wakai Y; Kowatari K; Nitobe T; Mizushima Y
    Mod Rheumatol; 2006; 16(6):410-1. PubMed ID: 17165006
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adalimumab vasculitis in a patient with Crohn's disease].
    Muñoz Villafranca C; Izu Belloso RM; Bravo Rodriguez MT; Basterra Olabarrieta S
    Gastroenterol Hepatol; 2013 Apr; 36(4):296-7. PubMed ID: 23522950
    [No Abstract]   [Full Text] [Related]  

  • 18. Leukocytoclastic vasculitis induced by low-dose methotrexate: in vitro evidence for an immunologic mechanism.
    Halevy S; Giryes H; Avinoach I; Livni E; Sukenik S
    J Eur Acad Dermatol Venereol; 1998 Jan; 10(1):81-5. PubMed ID: 9552765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Summaries for patients. Adding infliximab to the treatment regimen for polymyalgia rheumatica.
    Ann Intern Med; 2007 May; 146(9):I20. PubMed ID: 17470827
    [No Abstract]   [Full Text] [Related]  

  • 20. Vasculitides induced by TNFalpha antagonists: a study in 39 patients in France.
    Saint Marcoux B; De Bandt M;
    Joint Bone Spine; 2006 Dec; 73(6):710-3. PubMed ID: 17127088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.